Eli Lilly and WHO Warn Against Counterfeit Weight Loss Drugs, Plan Legal Action

TL;DR Summary
The World Health Organization and Eli Lilly are warning about fake versions of popular weight-loss and diabetes drugs, including Wegovy, Ozempic, and Mounjaro. Reports of counterfeit semaglutide and tirzepatide have surfaced globally. Eli Lilly is suing entities selling fake tirzepatide products and emphasizes that it is the only lawful supplier. Patients are advised to use prescriptions from licensed physicians and avoid unfamiliar sources. Demand for these drugs is high, with some expected to be in limited supply through the second quarter.
- WHO warns about fake versions of weight loss drugs Wegovy and Zepbound NBC News
- Fake Weight Loss Drugs: What To Know As Eli Lilly Plans Lawsuits Against Mounjaro, Zepbound Counterfeiters Forbes
- Medical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide) World Health Organization (WHO)
- Eli Lilly sues weight loss drug knockoff sellers Axios
- Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products | Eli Lilly and Company Investors | Eli Lilly and Company
Reading Insights
Total Reads
0
Unique Readers
12
Time Saved
1 min
vs 2 min read
Condensed
68%
256 → 81 words
Want the full story? Read the original article
Read on NBC News